> For the complete documentation index, see [llms.txt](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/llms.txt). Markdown versions of documentation pages are available by appending `.md` to page URLs; this page is available as [Markdown](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines.md).

# Natural medicines

- [Overview](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/overview.md): Overview of the natural medicines library, including compound hubs such as Withaferin A and practical guidance on liposomal delivery
- [Direct links to our natural medicines in oncology deep dives and FB group's conversation threads](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/direct-links-to-our-natural-medicines-in-oncology-deep-dives-and-fb-groups-conversation-threads.md): Overview of the natural medicines library, including deep dives, liposomal delivery guidance, and the A–Z group discussion thread index
- [Berberine in Oncology](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/berberine-in-oncology.md): Deep-dive guide to berberine in oncology, including mechanisms, evidence summary, pharmacology context, and safety cautions
- [Evidence Summary](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/berberine-in-oncology/evidence-summary.md): Evidence-based summary of berberine in oncology, including strengths, limits, clinical positioning, and key treatment considerations
- [Anticancer Mechanisms](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/berberine-in-oncology/anticancer-mechanisms.md): Primary anti-cancer mechanisms of berberine and why they matter in oncology research
- [Redox Dual Action](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/berberine-in-oncology/anticancer-mechanisms/redox-dual-action.md): Context-dependent oxidative and antioxidant activity of berberine in cancer biology
- [Glucose, Glutamine & the Warburg Effect](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/berberine-in-oncology/anticancer-mechanisms/glucose-glutamine-and-the-warburg-effect.md): How berberine disrupts glucose uptake, glycolysis, and glutamine dependence in cancer cells
- [Ferroptosis Findings](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/berberine-in-oncology/anticancer-mechanisms/ferroptosis-findings.md): Emerging evidence that berberine can promote ferroptosis in selected cancer models
- [NRF2 Impact](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/berberine-in-oncology/anticancer-mechanisms/nrf2-impact.md): Context-dependent berberine effects on the Nrf2 pathway and why that matters in oncology
- [Berberine Evidence by Cancer Type](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/berberine-in-oncology/berberine-evidence-by-cancer-type.md): Cancer-type guide to berberine in oncology research, including colorectal, breast, lung, gastric, gynaecological, and brain-tumour evidence
- [Breast Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/berberine-in-oncology/berberine-evidence-by-cancer-type/breast-cancer.md): Evidence-based overview of berberine in breast cancer, including TNBC, ER-positive, and HER2-positive resistance-reversal research
- [Lung Cancer (NSCLC)](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/berberine-in-oncology/berberine-evidence-by-cancer-type/lung-cancer-nsclc.md): Evidence-based overview of berberine in non-small-cell lung cancer, including p53-independent growth arrest, cancer-stem-cell effects, and ferroptosis-linked findings
- [Gastric Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/berberine-in-oncology/berberine-evidence-by-cancer-type/gastric-cancer.md): Evidence-based overview of berberine in gastric cancer, including JAK2/STAT3 inhibition, glycolysis effects, and low-glucose synergy
- [Colorectal Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/berberine-in-oncology/berberine-evidence-by-cancer-type/colorectal-cancer.md): Evidence-based overview of berberine in colorectal cancer, including adenoma-prevention data, microbiome relevance, and cetuximab-sensitisation research
- [Gynaecological Cancers](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/berberine-in-oncology/berberine-evidence-by-cancer-type/gynaecological-cancers.md): Evidence-based overview of berberine in ovarian, cervical, and endometrial cancers, including metastasis, HPV, and PI3K/Akt-related findings
- [Glioblastoma & Brain Tumours](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/berberine-in-oncology/berberine-evidence-by-cancer-type/glioblastoma-and-brain-tumours.md): Evidence-based overview of berberine in glioblastoma and brain-tumour research, including autophagy, glycolysis pressure, and delivery challenges
- [Immune Effects](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/berberine-in-oncology/immune-effects.md): How berberine may remodel the tumour microenvironment, reduce PD-L1 signalling, and support anti-tumour immunity
- [Antimicrobial / Antifungal Activity](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/berberine-in-oncology/antimicrobial-antifungal-activity.md): Berberine's antimicrobial and antifungal activity, including H. pylori, Fusobacterium nucleatum, Candida, and microbiome relevance in oncology
- [Pharmacokinetics & Metabolism](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/berberine-in-oncology/pharmacokinetics-and-metabolism.md): Berberine bioavailability limits, gut-microbiome conversion, tissue distribution, and formulation considerations in oncology
- [Safety & Interactions](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/berberine-in-oncology/safety-and-interactions.md): Berberine safety profile, CYP and P-glycoprotein interaction risks, and monitoring considerations in oncology
- [Dosing & Timing](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/berberine-in-oncology/dosing-and-timing.md): Berberine dosing ranges, meal timing, fasting context, and formulation-adjusted use in oncology discussions
- [Berberine & Metformin](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/berberine-in-oncology/berberine-and-metformin.md): Why berberine and metformin are usually better used as a continuous metabolic backbone rather than alternated in cycles
- [Boswellia in Oncology](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology.md)
- [Boswellia in Oncology Overview](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/boswellia-in-oncology-overview.md): What Boswellia is, how it relates to frankincense, and why AKBA matters in oncology
- [Evidence Summary](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/evidence-summary.md): Evidence-based summary of Boswellia in oncology, including AKBA strengths, clinical positioning, and treatment considerations
- [Anticancer Mechanisms](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/anticancer-mechanisms.md): Primary anti-cancer mechanisms of Boswellia and AKBA in oncology research
- [Boswellia Evidence by Cancer Type](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/boswellia-evidence-by-cancer-type.md): Cancer-type guide to Boswellia in oncology, including glioblastoma, breast, colorectal, pancreatic, prostate, lung, ovarian, and related research
- [Glioblastoma & Brain Tumours](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/boswellia-evidence-by-cancer-type/glioblastoma-and-brain-tumours.md): Evidence-based overview of Boswellia in glioblastoma and brain tumours, including cerebral oedema and radiosensitisation relevance
- [Breast Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/boswellia-evidence-by-cancer-type/breast-cancer.md): Evidence-based overview of Boswellia in breast cancer, including Phase Ia human data, EGFR signalling, and apoptosis research
- [Colorectal Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/boswellia-evidence-by-cancer-type/colorectal-cancer.md): Evidence-based overview of Boswellia in colorectal cancer, including orthotopic model data, miRNA effects, and invasion suppression
- [Pancreatic Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/boswellia-evidence-by-cancer-type/pancreatic-cancer.md): Evidence-based overview of Boswellia in pancreatic cancer, including orthotopic tumour suppression and COX-2-related mechanisms
- [Prostate Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/boswellia-evidence-by-cancer-type/prostate-cancer.md): Evidence-based overview of Boswellia in prostate cancer, including docetaxel-resistance reversal and Akt / STAT3 suppression
- [Non-Small Cell Lung Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/boswellia-evidence-by-cancer-type/non-small-cell-lung-cancer.md): Evidence-based overview of Boswellia in NSCLC, including cisplatin sensitisation and radioresistance reversal
- [Ovarian Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/boswellia-evidence-by-cancer-type/ovarian-cancer.md): Evidence-based overview of Boswellia in ovarian cancer, including taxane-resistance and multidrug-resistance findings
- [Other Cancer Types](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/boswellia-evidence-by-cancer-type/other-cancer-types.md): Additional Boswellia oncology evidence across liver, gastric, haematologic, melanoma, and other cancer models
- [Redox Dual Action](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/redox-dual-action.md): Context-dependent oxidative and anti-inflammatory activity of Boswellia and AKBA
- [NRF2 Impact](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/nrf2-impact.md): Context-dependent Nrf2 interpretation for Boswellia and AKBA in oncology
- [Ferroptosis Findings](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/ferroptosis-findings.md): Emerging ferroptosis relevance of Boswellia and AKBA in resistant tumour biology
- [Immune Effects](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/immune-effects.md): How Boswellia/AKBA modulates inflammatory mediators and anti-tumour immune function
- [Pharmacokinetics & Metabolism](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/pharmacokinetics-and-metabolism.md): How Boswellia and AKBA are absorbed, metabolised, and limited by bioavailability
- [Safety & Interactions](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/safety-and-interactions.md): Safety profile, CYP interactions, anticoagulant cautions, and monitoring considerations for Boswellia in oncology
- [Synergistic Combinations](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/synergistic-combinations.md): How Boswellia and AKBA may combine with chemotherapy, radiotherapy, and other natural compounds
- [Hydroxychloroquine + Boswellia](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/hydroxychloroquine-+-boswellia.md): Special report on hydroxychloroquine and Boswellia / AKBA as a dual autophagy-blocking strategy, including prostate-cancer evidence and cardiac cautions
- [Dosing & Timing](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/dosing-and-timing.md): Boswellia and AKBA dosing logic, clinical trial ranges, food timing, and formulation considerations
- [Sourcing Quality Boswellia](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/sourcing-quality-boswellia.md): How to judge Boswellia extract quality, AKBA standardisation, and formulation relevance for oncology-oriented use
- [Curcumin in Oncology](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology.md)
- [Curcumin in Oncology Overview](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/curcumin-in-oncology-overview.md): What curcumin is, why it is studied in oncology, and where the evidence is strongest across prevention and adjunctive care
- [Evidence Summary](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/evidence-summary.md): Evidence-based summary of curcumin in oncology, including clinical positioning, advantages, limitations, and treatment considerations
- [Anticancer Mechanisms](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/anticancer-mechanisms.md): Primary anti-cancer mechanisms of curcumin
- [Redox Dual Action](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/anticancer-mechanisms/redox-dual-action.md): Context-dependent curcumin redox activity explaining selective toxicity toward cancer cells
- [NRF2 Impact](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/anticancer-mechanisms/nrf2-impact.md): Curcumin's activation of the Nrf2 pathway and why it matters clinically
- [Ferroptosis Findings](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/anticancer-mechanisms/ferroptosis-findings.md): Emerging evidence that curcumin can induce ferroptosis in resistant cancer cells
- [Curcumin Evidence by Cancer Type](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/curcumin-evidence-by-cancer-type.md): Cancer-type guide to curcumin in oncology, including colorectal, breast, pancreatic, lung, prostate, gastric, head and neck, and blood cancer research
- [Blood Cancers](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/curcumin-evidence-by-cancer-type/blood-cancers.md): Evidence-based overview of curcumin in blood cancers, including myeloma, CLL, ALL, and lymphoma research
- [Colorectal Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/curcumin-evidence-by-cancer-type/colorectal-cancer.md): Evidence-based overview of curcumin in colorectal cancer, including chemoprevention, FOLFOX synergy, stem-cell targeting, and resistance data
- [Breast Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/curcumin-evidence-by-cancer-type/breast-cancer.md): Evidence-based overview of curcumin in breast cancer, including subtype-specific data, taxane synergy, radiotherapy support, and resistance research
- [Pancreatic Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/curcumin-evidence-by-cancer-type/pancreatic-cancer.md): Evidence-based overview of curcumin in pancreatic cancer, including Phase II clinical data and gemcitabine-sensitising research
- [Lung Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/curcumin-evidence-by-cancer-type/lung-cancer.md): Evidence-based overview of curcumin in lung cancer and other lung cancers: mechanisms, preclinical findings, and clinical direction
- [Prostate Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/curcumin-evidence-by-cancer-type/prostate-cancer.md): Evidence-based overview of curcumin in prostate cancer: human trial data, pathway-specific mechanisms, and honest assessment of the evidence
- [Head & Neck Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/curcumin-evidence-by-cancer-type/head-and-neck-cancer.md): Evidence-based overview of curcumin in head and neck cancer, including mucositis support and anti-metastatic findings
- [Gastric Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/curcumin-evidence-by-cancer-type/gastric-cancer.md): Evidence-based overview of curcumin in gastric cancer, including H. pylori relevance and inflammation-linked mechanisms
- [Immune Effects](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/immune-effects.md): How curcumin may support anti-tumour immune function
- [Antimicrobial / Antifungal Activity](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/antimicrobial-antifungal-activity.md): Curcumin's antimicrobial properties and their possible relevance to cancer biology
- [Pharmacokinetics & Metabolism](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/pharmacokinetics-and-metabolism.md): Curcumin bioavailability, drug interactions, and delivery considerations
- [Dosing & Timing](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/dosing-and-timing.md): Curcumin timing, dosing logic, and clinically relevant formulation considerations
- [Safety & Interactions](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/safety-and-interactions.md): Curcumin safety profile, contraindications, and monitoring considerations
- [Synergistic Combinations](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/synergistic-combinations.md): Curcumin combinations with chemotherapy and natural compounds
- [Sourcing Quality Curcumin](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/sourcing-quality-curcumin.md): How to judge curcumin supplement quality, bioavailability, actual curcuminoid strength, and real-world value for oncology-oriented use
- [Deuterium-Depleted Water (DDW)](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/deuterium-depleted-water-ddw.md): DDW section landing page covering what it is, why it matters in oncology, protocol questions, evidence by cancer type, and where to jump next
- [DDW Evidence by Cancer Type](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/deuterium-depleted-water-ddw/ddw-evidence-by-cancer-type.md): Cancer-type guide to DDW in oncology research, including pancreatic, colorectal, breast, lung, nasopharyngeal, prostate, and mixed-clinical settings
- [DDW and Pancreatic Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/deuterium-depleted-water-ddw/ddw-evidence-by-cancer-type/ddw-and-pancreatic-cancer.md): Evidence-based overview of DDW in pancreatic cancer, including the 2021 adjunctive chemotherapy survival study and its limits
- [DDW Protocol Variation and Lower Limits](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/deuterium-depleted-water-ddw/ddw-protocol-variation-and-lower-limits.md): Why DDW experts differ on how low to go, including the Somlyai step-down model, the ~80 ppm caution, and the glycocalyx theory
- [DDW Sourcing and Brand Options](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/deuterium-depleted-water-ddw/ddw-sourcing-and-brand-options.md): Practical guide to DDW product formats, ppm options, mixing logic, and how to think about brands without overstating differences
- [EGCG in Oncology](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/egcg-in-oncology.md)
- [EGCG in Oncology Overview](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/egcg-in-oncology/egcg-in-oncology-overview.md): What EGCG is, how it relates to green tea, and why it is studied in oncology
- [Evidence Summary](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/egcg-in-oncology/evidence-summary.md): Evidence-based summary of EGCG in oncology, including clinical positioning, strengths, limitations, and treatment considerations
- [Anticancer Mechanisms](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/egcg-in-oncology/anticancer-mechanisms.md): Primary anti-cancer mechanisms of EGCG and the green tea catechin evidence base
- [EGCG Evidence by Cancer Type](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/egcg-in-oncology/egcg-evidence-by-cancer-type.md): Cancer-type guide to EGCG in oncology, including breast, pancreatic, colorectal, lung, prostate, blood, and oral cancer research
- [Breast Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/egcg-in-oncology/egcg-evidence-by-cancer-type/breast-cancer.md): Evidence-based overview of EGCG in breast cancer, including subtype-specific data, treatment synergy, and recurrence-related research
- [Pancreatic Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/egcg-in-oncology/egcg-evidence-by-cancer-type/pancreatic-cancer.md): Evidence-based overview of EGCG in pancreatic cancer, including gemcitabine synergy and tumour-growth inhibition research
- [Colorectal Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/egcg-in-oncology/egcg-evidence-by-cancer-type/colorectal-cancer.md): Evidence-based overview of EGCG in colorectal cancer, including chemoprevention, local GI relevance, and 5-FU-related research
- [Lung Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/egcg-in-oncology/egcg-evidence-by-cancer-type/lung-cancer.md): Evidence-based overview of EGCG in lung cancer, including EGFR relevance, NSCLC research, and ferroptosis-related findings
- [Prostate Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/egcg-in-oncology/egcg-evidence-by-cancer-type/prostate-cancer.md): Evidence-based overview of EGCG in prostate cancer, including prevention trials, biomarker effects, and androgen-related relevance
- [Blood Cancers](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/egcg-in-oncology/egcg-evidence-by-cancer-type/blood-cancers.md): Evidence-based overview of EGCG in blood cancers, including CLL, leukaemia, lymphoma, and bortezomib-related cautions
- [Oral / Head & Neck Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/egcg-in-oncology/egcg-evidence-by-cancer-type/oral-head-and-neck-cancer.md): Evidence-based overview of EGCG in oral and head and neck cancers, including topical relevance and invasion-related findings
- [Other Cancer Types](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/egcg-in-oncology/egcg-evidence-by-cancer-type/other-cancer-types.md): Additional EGCG oncology evidence across ovarian, gastric, liver, and other cancer models
- [Immune Effects](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/egcg-in-oncology/immune-effects.md): How EGCG and the main green tea catechin may support anti-tumour immune function
- [Pharmacokinetics & Metabolism](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/egcg-in-oncology/pharmacokinetics-and-metabolism.md): How EGCG is absorbed, metabolised, and limited by poor oral bioavailability in oncology use
- [Dosing & Timing](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/egcg-in-oncology/dosing-and-timing.md): EGCG dosing logic for prevention, adjunctive use, bioavailability, and treatment timing
- [Safety & Interactions](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/egcg-in-oncology/safety-and-interactions.md): Safety profile, liver risk, drug interactions, and bortezomib caution for EGCG in oncology
- [Sourcing Quality EGCG](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/egcg-in-oncology/sourcing-quality-egcg.md): How to judge EGCG supplement quality, green tea extract strength, caffeine issues, and bioavailability considerations
- [Liposomal Encapsulation of Anti-cancer Compounds](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/liposomal-encapsulation-of-anti-cancer-compounds.md): Why empty liposomes matter, how to use them, and safety-focused guides to liposomal melatonin and ivermectin
- [Why Empty Liposomes Matter](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/liposomal-encapsulation-of-anti-cancer-compounds/why-empty-liposomes-matter.md): Why empty phosphatidylcholine liposomes may have biological activity of their own, and why that matters here
- [Safety, Timing, and Stacking Cautions](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/liposomal-encapsulation-of-anti-cancer-compounds/safety-timing-and-stacking-cautions.md): Key safety considerations when combining liposomal delivery with lipophilic drugs or supplements
- [How to Use Liposence® Empty Liposomes](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/liposomal-encapsulation-of-anti-cancer-compounds/how-to-use-liposence-r-empty-liposomes.md): Practical notes on choosing ingredients, mixing, storage, and everyday use of Liposence empty liposomes
- [DIY Liposomal Melatonin](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/liposomal-encapsulation-of-anti-cancer-compounds/diy-liposomal-melatonin.md): Recipe notes, costing logic, storage, and comparison points for DIY liposomal melatonin using empty liposomes
- [Liposomal Ivermectin](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/liposomal-encapsulation-of-anti-cancer-compounds/liposomal-ivermectin.md): Experimental evidence, formulation notes, recipe math, and safety cautions for liposomal ivermectin
- [Nebulising Liposomal Formulations](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/liposomal-encapsulation-of-anti-cancer-compounds/nebulising-liposomal-formulations.md): Advanced note on nebulised liposomal delivery, with pulmonary uptake, retention, and safety references
- [Melatonin in Oncology - Study Notes](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/melatonin-in-oncology-study-notes.md): Study-note hub covering melatonin's mitochondrial, immune, phase-separation, fibrotic, and dosing questions in oncology research
- [High-Dose Mitochondria, RET, and ROS](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/melatonin-in-oncology-study-notes/high-dose-mitochondria-ret-and-ros.md): How high-dose melatonin may push cancer-cell mitochondria into reverse electron transport, ROS surge, uncoupling, and apoptosis
- [Dosing, Bioavailability, and Human Scaling](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/melatonin-in-oncology-study-notes/dosing-bioavailability-and-human-scaling.md): How the mouse and cell data translate into exposure estimates, oral-bioavailability limits, and practical high-dose caveats
- [Moderate-Dose Immune Effects and Timing](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/melatonin-in-oncology-study-notes/moderate-dose-immune-effects-and-timing.md): Why moderate evening melatonin is discussed as a Th1-supportive adjunct, and where it may fit in the cancer-immunity cycle
- [Phase Separation in Oncology](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/melatonin-in-oncology-study-notes/phase-separation-in-oncology.md): How melatonin is being discussed as a regulator of oncogenic condensates, redox state, scaffold plasticity, and electrostatic balance
- [Fibrotic Drivers and the 26-Gene Signature](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/melatonin-in-oncology-study-notes/fibrotic-drivers-and-the-26-gene-signature.md): How melatonin's proposed condensate-linked gene set overlaps with fibrosis, EMT, YAP/TAZ, β-catenin, and stromal remodelling
- [Addendum — Dosing, Th1/Th2, and Recalibration](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/melatonin-in-oncology-study-notes/addendum-dosing-th1-th2-and-recalibration.md): Why continuous high-dose oral melatonin may undermine the immune-support goal, and how to think about recalibrating use
- [Melatonin, Palbociclib, and Cyclin D1](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/melatonin-in-oncology-study-notes/melatonin-palbociclib-and-cyclin-d1.md): Preclinical ER-positive breast-cancer study suggesting melatonin may blunt palbociclib-related cyclin D1 up-regulation and deepen G1 arrest
- [Polydatin in Oncology](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology.md)
- [Polydatin in Oncology Overview](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/polydatin-in-oncology-overview.md): What polydatin is and where the evidence is strongest in oncology research.
- [Evidence Summary](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/evidence-summary.md): Evidence-based summary of polydatin in oncology, including advantages, limitations, clinical positioning, and key treatment considerations
- [Anticancer Mechanisms](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/anticancer-mechanisms.md): Primary anti-cancer mechanisms of Polydatin
- [G6PD Inhibition](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/anticancer-mechanisms/g6pd-inhibition.md): Polydatin G6PD inhibition, including cancer types showing particular G6PD-dependent vulnerability
- [Redox Dual Action](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/anticancer-mechanisms/redox-dual-action.md): Context-dependent polydatin redox activity explaining selective toxicity toward cancer cells while sparing normal tissues
- [NRF2 Impact](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/anticancer-mechanisms/nrf2-impact.md): Polydatin effects on the Nrf2 pathway and why that context matters in oncology
- [Ferroptosis Findings](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/anticancer-mechanisms/ferroptosis-findings.md): Emerging ferroptosis relevance of polydatin in cancer biology and treatment resistance
- [CYP1B1 Rescue Mechanism](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/anticancer-mechanisms/cyp1b1-rescue-mechanism.md): Includes Discussion of Polydatin's Unique Mechanisms for Anti-Cancer, Antimicrobial and Anti-fungal Activity
- [GLUT uptake advantage](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/anticancer-mechanisms/glut-uptake-advantage.md): Polydatin carries a glucose moiety, structurally recognised by GLUT transporters to a degree that resveratrol is not.
- [Polydatin Evidence by Cancer Type](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/polydatin-evidence-by-cancer-type.md): Cancer-type guide to polydatin in oncology research findings, including colorectal, breast, lung, liver, oral, blood, and bone cancer research
- [Colorectal Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/polydatin-evidence-by-cancer-type/colorectal-cancer.md): Evidence-based overview of polydatin in colorectal cancer, including radiosensitisation, oxaliplatin synergy, and mechanism data
- [Breast Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/polydatin-evidence-by-cancer-type/breast-cancer.md): Evidence-based overview of polydatin across breast cancers, including signalling effects, cautions, and
- [Lung Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/polydatin-evidence-by-cancer-type/lung-cancer.md): Evidence-based overview of polydatin in lung cancer, including apoptosis, cell-cycle arrest, and cisplatin-synergy findings
- [Liver Cancer (HCC)](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/polydatin-evidence-by-cancer-type/liver-cancer-hcc.md): Evidence-based overview of polydatin in liver cancer, including tumour selectivity, apoptosis, and chemotherapy-sensitising effects
- [Oral Cancer (OSCC)](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/polydatin-evidence-by-cancer-type/oral-cancer-oscc.md): Evidence-based overview of polydatin in oral cancer, including G6PD inhibition, anti-metastatic effects, and orthotopic model data
- [Blood Cancers](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/polydatin-evidence-by-cancer-type/blood-cancers.md): Evidence-based overview of polydatin in blood cancers, including AML and ALL findings on apoptosis, autophagy, and growth inhibition
- [Osteosarcoma](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/polydatin-evidence-by-cancer-type/osteosarcoma.md): Evidence-based overview of polydatin in osteosarcoma, including radiosensitisation, apoptosis, and doxorubicin-resistance findings
- [Other Cancer Types](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/polydatin-evidence-by-cancer-type/other-cancer-types.md): Additional polydatin oncology evidence across nasopharyngeal, cervical, ovarian, and other cancer models - work in progress
- [HER2+ Cancers](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/polydatin-evidence-by-cancer-type/her2+-cancers.md): HER2-positive breast-cancer caution for polydatin and the current Δ16HER2 / resveratrol concern
- [Immune Effects](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/immune-effects.md): Polydatin blocks G6PD, and G6PD blockade may help trigger anti-tumour immune effects
- [Antimicrobial / Antifungal Activity](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/antimicrobial-antifungal-activity.md): Polydatin antimicrobial and antifungal activity, including tumour-mycobiome relevance
- [Pharmacokinetics & Metabolism](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/pharmacokinetics-and-metabolism.md): Polydatin bioavailability, drug interactions, and delivery considerations
- [Safety & Interactions](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/safety-and-interactions.md): Safety profile, interaction risks, and practical considerations for polydatin in oncology
- [Dosing & Timing](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/dosing-and-timing.md): Polydatin dosing logic, timing, and formulation considerations in oncology use
- [Polydatin / Resveratrol Comparison](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/polydatin-resveratrol-comparison.md): Comparison of polydatin and resveratrol, including mechanism, uptake, and bioavailability differences
- [Sourcing Quality Polydatin](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/sourcing-quality-polydatin.md): How to judge polydatin supplement quality, bioavailability, strength, and real-world value for oncology-oriented use
- [PDF Pack](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/pdf-pack.md): Export-friendly ordered pack for Polydatin pages
- [Shikonin in Oncology](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/shikonin-in-oncology.md): Deep-dive guide to shikonin in oncology, including mechanisms, immune effects, evidence by cancer type, pharmacokinetics, and safety cautions
- [Evidence Summary](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/shikonin-in-oncology/evidence-summary.md): Evidence-based summary of shikonin in oncology, including strengths, limitations, clinical positioning, and treatment considerations
- [Anticancer Mechanisms](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/shikonin-in-oncology/anticancer-mechanisms.md): Primary anticancer mechanisms of shikonin and why they matter in oncology research
- [Immune Effects](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/shikonin-in-oncology/immune-effects.md): How shikonin may affect immunogenic cell death, tumour-associated macrophages, and the wider tumour microenvironment
- [Shikonin Evidence by Cancer Type](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/shikonin-in-oncology/shikonin-evidence-by-cancer-type.md): Cancer-type guide to shikonin in oncology research across breast, bladder, oesophageal, ovarian, cervical, lung, and thyroid cancer settings
- [Breast Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/shikonin-in-oncology/shikonin-evidence-by-cancer-type/breast-cancer.md): Evidence-based overview of shikonin in breast cancer, including ER-pathway disruption, PKM2 relevance, necroptosis, and tamoxifen synergy
- [Bladder Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/shikonin-in-oncology/shikonin-evidence-by-cancer-type/bladder-cancer.md): Evidence-based overview of shikonin in bladder cancer, including PKM2-driven resistance reversal, necroptosis, and cisplatin sensitisation
- [Oesophageal Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/shikonin-in-oncology/shikonin-evidence-by-cancer-type/oesophageal-cancer.md): Evidence-based overview of shikonin in oesophageal squamous cell carcinoma, including PKM2 and STAT3-linked glycolysis suppression
- [Ovarian Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/shikonin-in-oncology/shikonin-evidence-by-cancer-type/ovarian-cancer.md): Evidence-based overview of shikonin in ovarian cancer, including exosome biology, β-catenin signalling, and macrophage effects
- [Cervical Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/shikonin-in-oncology/shikonin-evidence-by-cancer-type/cervical-cancer.md): Evidence-based overview of shikonin in cervical cancer, including EMT suppression and PI3K/AKT/mTOR-related findings
- [Lung Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/shikonin-in-oncology/shikonin-evidence-by-cancer-type/lung-cancer.md): Evidence-based overview of shikonin in lung cancer, including PI3K/AKT/mTOR signalling and gefitinib sensitisation relevance
- [Thyroid Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/shikonin-in-oncology/shikonin-evidence-by-cancer-type/thyroid-cancer.md): Evidence-based overview of shikonin in anaplastic thyroid cancer, including the current ferroptosis signal and its limits
- [Pharmacokinetics & Metabolism](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/shikonin-in-oncology/pharmacokinetics-and-metabolism.md): Shikonin bioavailability limits, metabolism, formulation challenges, and why delivery remains the main translational barrier
- [Safety & Interactions](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/shikonin-in-oncology/safety-and-interactions.md): Shikonin safety profile, liver biology, CYP450 interaction evidence, endocrine-treatment questions, and key interaction limits in oncology use.
- [Dosing & Timing](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/shikonin-in-oncology/dosing-and-timing.md): What the research used, what the one human clinical signal shows, and why no established dose exists for oncology use.
- [Sourcing Quality Shikonin](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/shikonin-in-oncology/sourcing-quality-shikonin.md): How to judge shikonin product quality, why standardisation matters, and what current market limits still look like
- [Synergistic Combinations](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/shikonin-in-oncology/synergistic-combinations.md): Preclinical shikonin combination data across endocrine therapy, chemotherapy, and targeted therapy contexts
- [Sensitisation to Conventional Therapies](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/shikonin-in-oncology/sensitisation-to-conventional-therapies.md): How shikonin may re-open treatment sensitivity through PKM2 inhibition, ER-pathway disruption, and non-apoptotic cell death
- [PKM2 & the Warburg Effect](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/shikonin-in-oncology/pkm2-and-the-warburg-effect.md): Why PKM2 is the central shikonin mechanism, how it links to the Warburg effect, and why that matters across cancer types
- [Shikonon's Estrogen Receptor Mechanisms](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/shikonin-in-oncology/shikonons-estrogen-receptor-mechanisms.md): Detailed breakdown of Shikonin's ERα, GPER, steroid-sulfatase, and downstream signalling effects in hormone-driven cancer models
- [Silymarin / Milk Thistle in Oncology](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology.md)
- [Silymarin / Milk Thistle in Oncology Overview](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/silymarin-milk-thistle-in-oncology-overview.md): What silymarin is, how it relates to milk thistle, and why it matters in oncology for liver protection, treatment support, and anticancer research
- [Evidence Summary](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/evidence-summary.md): Evidence-based summary of silymarin and milk thistle in oncology, including liver protection, clinical positioning, advantages, and limitations
- [Anticancer Mechanisms](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/anticancer-mechanisms.md): Primary anti-cancer mechanisms of silymarin and milk thistle
- [Redox Dual Action](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/anticancer-mechanisms/redox-dual-action.md): Context-dependent redox activity of silymarin and milk thistle in cancer biology
- [Silymarin / Milk Thistle Evidence by Cancer Type](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/silymarin-milk-thistle-evidence-by-cancer-type.md): Cancer-type guide to silymarin and milk thistle in oncology, including breast, prostate, colorectal, liver, skin, lung, pancreatic, bladder, and ovarian cancer research
- [Breast Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/silymarin-milk-thistle-evidence-by-cancer-type/breast-cancer.md): Evidence-based overview of silymarin and milk thistle in breast cancer, including chemotherapy support, signalling effects, and radiotherapy relevance
- [Prostate Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/silymarin-milk-thistle-evidence-by-cancer-type/prostate-cancer.md): Evidence-based overview of silymarin and milk thistle in prostate cancer, including chemoprevention and androgen-pathway research
- [Colorectal Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/silymarin-milk-thistle-evidence-by-cancer-type/colorectal-cancer.md): Evidence-based overview of silymarin and milk thistle in colorectal cancer, including chemotherapy synergy and PD-L1 findings
- [Liver Cancer (HCC)](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/silymarin-milk-thistle-evidence-by-cancer-type/liver-cancer-hcc.md): Evidence-based overview of silymarin and milk thistle in liver cancer, including fasting-mimetic findings and hepatoprotective relevance
- [Melanoma and Other Skin Cancers](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/silymarin-milk-thistle-evidence-by-cancer-type/melanoma-and-other-skin-cancers.md): Evidence-based overview of silymarin and milk thistle in skin cancer, including UV-related chemoprevention and radiodermatitis relevance
- [Lung Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/silymarin-milk-thistle-evidence-by-cancer-type/lung-cancer.md): Evidence-based overview of silymarin and milk thistle in lung cancer, including apoptosis, cell-cycle arrest, and anti-angiogenic findings
- [Pancreatic Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/silymarin-milk-thistle-evidence-by-cancer-type/pancreatic-cancer.md): Evidence-based overview of silymarin and milk thistle in pancreatic cancer, including proliferative signalling, apoptosis, metastasis, metabolism, and cachexia
- [Bladder Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/silymarin-milk-thistle-evidence-by-cancer-type/bladder-cancer.md): Evidence-based overview of silymarin and bladder cancer, including effects on proliferative signalling, apoptosis, invasion and metastasis, epithelial–mesenchymal transition, and stress‑response path.
- [Ovarian Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/silymarin-milk-thistle-evidence-by-cancer-type/ovarian-cancer.md): Evidence‑based overview of silymarin and ovarian cancer, including proliferative signalling, apoptosis and cell‑cycle arrest, EMT and metastasis, platinum sensitisation, and related gyno contexts.
- [Cervical Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/silymarin-milk-thistle-evidence-by-cancer-type/cervical-cancer.md): Evidence‑based overview of silymarin and cervical cancer, including effects on signalling, apoptosis, G2/M cell‑cycle arrest, stress‑response MAPK pathways, IC potential.
- [Chemotherapy & Radiation Synergy](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/chemotherapy-and-radiation-synergy.md): How silymarin and milk thistle may enhance treatment while protecting healthy tissue
- [Immune Modulation & PD-L1](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/immune-modulation-and-pd-l1.md): Emerging immune-oncology relevance of silymarin and milk thistle
- [Nrf2 & NF-κB Pathway Deep Dive](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/nrf2-and-nf-kb-pathway-deep-dive.md): Context-dependent pathway interpretation for silymarin and milk thistle in oncology
- [Pharmacokinetics, Bioavailability & Dosing](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/pharmacokinetics-bioavailability-and-dosing.md): How silymarin and milk thistle are absorbed, processed, and dosed in research
- [Safety, Interactions & Considerations](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/safety-interactions-and-considerations.md): Safety profile, interaction risks, and clinical considerations for silymarin and milk thistle
- [Sourcing & Product Quality](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/sourcing-and-product-quality.md): How to judge milk thistle and silymarin supplement quality, standardisation, strength, and product value for oncology-oriented use
- [Urolithin A in Oncology](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology.md): Deep-dive guide to Urolithin A in oncology, including mechanisms, immune effects, evidence by cancer type, pharmacokinetics, and safety cautions
- [Evidence Summary](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/evidence-summary.md): Evidence-based summary of Urolithin A in oncology, including strengths, limitations, clinical positioning, and treatment considerations
- [Anticancer Mechanisms](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/anticancer-mechanisms.md): Primary anticancer mechanisms of Urolithin A and why they matter in oncology research
- [Immune Effects](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/immune-effects.md): How Urolithin A may affect NK cells, CD8-positive T cells, macrophage behaviour, and immunotherapy-relevant biology
- [Synergistic Combinations](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/synergistic-combinations.md): How Urolithin A may combine with immunotherapy and selected standard therapies in oncology research
- [Urolithin A Evidence by Cancer Type](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/urolithin-a-evidence-by-cancer-type.md): Cancer-type guide to Urolithin A in oncology research across GI, hormonal, urothelial, liver, lung, brain, prostate, and bone-cancer settings
- [Colorectal Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/urolithin-a-evidence-by-cancer-type/colorectal-cancer.md): Evidence-based overview of Urolithin A in colorectal cancer, including Wnt signalling, AKT1-related immune effects, apoptosis, and chemotherapy-sensitisation research
- [Pancreatic Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/urolithin-a-evidence-by-cancer-type/pancreatic-cancer.md): Evidence-based overview of Urolithin A in pancreatic cancer, including PI3K/AKT/mTOR suppression, stromal remodelling, gemcitabine context, and anti-PD-1 sensitisation
- [Prostate Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/urolithin-a-evidence-by-cancer-type/prostate-cancer.md): Evidence-based overview of Urolithin A in prostate cancer, including androgen-receptor signalling, oxidative DNA damage, NK-cell activation, and the active URO-PRO trial
- [Breast Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/urolithin-a-evidence-by-cancer-type/breast-cancer.md): Evidence-based overview of Urolithin A in breast cancer, including ER-positive signalling, triple-negative macrophage effects, ABCG2 relevance, and key subtype limits
- [Endometrial Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/urolithin-a-evidence-by-cancer-type/endometrial-cancer.md): Evidence-based overview of Urolithin A in endometrial cancer, including ERα and ERβ modulation, G2/M arrest, and the current lack of in vivo or clinical data
- [Glioblastoma](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/urolithin-a-evidence-by-cancer-type/glioblastoma.md): Evidence-based overview of Urolithin A in glioblastoma, including blood-brain-barrier penetration, Sirt1-FOXO1 signalling, AKT and EGFR suppression, and tumour-microenvironment effects
- [Liver Cancer (HCC)](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/urolithin-a-evidence-by-cancer-type/liver-cancer-hcc.md): Evidence-based overview of Urolithin A in hepatocellular carcinoma, including β-catenin signalling, HBV-related mechanisms, Nrf2-related hepatoprotection, and gut-liver-axis relevance
- [Lung Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/urolithin-a-evidence-by-cancer-type/lung-cancer.md): Evidence-based overview of Urolithin A in lung cancer, including EMT inhibition, PI3K/AKT/mTOR suppression, autophagy, and in vivo xenograft findings
- [Osteosarcoma](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/urolithin-a-evidence-by-cancer-type/osteosarcoma.md): Evidence-based overview of Urolithin A in osteosarcoma, including anti-metastatic findings, AKT1 and EGFR relevance, and MMP2 and MMP9 suppression
- [Bladder Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/urolithin-a-evidence-by-cancer-type/bladder-cancer.md): Evidence-based overview of Urolithin A in bladder cancer, including UMUC3 sensitivity, G2/M arrest, apoptosis, and urinary-exposure relevance
- [Pharmacokinetics & Metabolism](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/pharmacokinetics-and-metabolism.md): Urolithin A bioavailability, microbiome-conversion limits, tissue-distribution questions, and supplementation implications
- [Safety & Interactions](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/safety-and-interactions.md): Human safety data, drug-interaction uncertainty, endocrine cautions, and immunotherapy-related considerations for Urolithin A
- [Dosing & Timing](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/dosing-and-timing.md): Human dose ranges, practical timing notes, and current dosing limits for Urolithin A in oncology discussions
- [Sourcing Quality Urolithin A](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/sourcing-quality-urolithin-a.md): How to judge Urolithin A supplement quality, compare real-world products, and avoid underdosed or misleading formulas
- [Antimicrobial, Antiviral & Terrain Support](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/antimicrobial-antiviral-and-terrain-support.md): Terrain-focused guide to Urolithin A across antibacterial, antiviral, antiparasitic, antifungal, gut-barrier, and microbiome-support evidence relevant to cancer care
- [Sensitisation to Conventional Therapies](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/sensitisation-to-conventional-therapies.md): How Urolithin A may sensitise cancer cells to chemotherapy, immunotherapy, and radiation across current preclinical and early human evidence
- [Usnic Acid / Usnea](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/usnic-acid-usnea.md): Evidence-based overview of usnic acid from Usnea, including anticancer mechanisms, antifungal crossover, dosing context, and safety cautions
- [Usnic Acid / Usnea in Oncology Overview](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/usnic-acid-usnea/usnic-acid-usnea-in-oncology-overview.md): What usnic acid is, why it is studied in oncology, and where the evidence is strongest
- [Evidence Summary](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/usnic-acid-usnea/evidence-summary.md): Evidence-based summary of usnic acid in oncology, including strengths, limitations, clinical positioning, and treatment considerations
- [Anticancer Mechanisms](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/usnic-acid-usnea/anticancer-mechanisms.md): Primary anticancer mechanisms of usnic acid and why they matter in oncology research
- [Biofilm Activity](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/usnic-acid-usnea/biofilm-activity.md): What usnic acid appears to do against fungal-bacterial biofilms and where its limits begin
- [Usnic Acid Evidence by Cancer Type](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/usnic-acid-usnea/usnic-acid-evidence-by-cancer-type.md): Cancer-type guide to usnic acid research findings across major tumour models
- [Antifungal / Antimicrobial Activity](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/usnic-acid-usnea/antifungal-antimicrobial-activity.md): Usnic acid's antifungal crossover relevance and why it matters in this documentation set
- [Synergy with Standard Therapies](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/usnic-acid-usnea/synergy-with-standard-therapies.md): Why usnic acid has drawn interest as a possible sensitising partner with selected cancer drugs
- [Safety & Hepatotoxicity](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/usnic-acid-usnea/safety-and-hepatotoxicity.md): Liver-risk context, selectivity, and why dose and formulation matter so much for usnic acid
- [Dosing & Timing](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/usnic-acid-usnea/dosing-and-timing.md): Practical tincture dosing context, cycling, standardisation limits, and timing considerations for usnic acid
- [Sourcing Quality Usnea / Usnic Acid](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/usnic-acid-usnea/sourcing-quality-usnea-usnic-acid.md): Product-quality considerations, standardisation problems, and example sourcing notes for usnea tinctures
- [Withaferin A (WFA) in Oncology](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology.md): A detailed overview of withaferin A in oncology, including mechanisms, evidence, pharmacokinetics, safety, dosing, and sourcing.
- [Evidence Summary](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/evidence-summary.md): The current evidence base for withaferin A in oncology, including strengths, limitations, and clinical status.
- [Immune Effects](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/immune-effects.md): The immune and tumour-microenvironment effects of withaferin A in oncology.
- [Synergistic Combinations](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/synergistic-combinations.md): Combination strategies for withaferin A, including chemotherapy, immunotherapy, and scheduling conflicts.
- [Anti-cancer Mechanisms](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/anti-cancer-mechanisms.md): The core anticancer mechanisms of withaferin A, including autophagy blockade, HSP90 disruption, vimentin targeting, and metabolic effects.
- [WFA vs Hydroxychloroquine for Autophagy Blockade](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/wfa-vs-hydroxychloroquine-for-autophagy-blockade.md): How withaferin A compares with hydroxychloroquine on mechanism, half-life, safety, pulsing, and interaction timing when autophagy blockade is the goal.
- [WFA Evidence by Cancer Type](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/wfa-evidence-by-cancer-type.md): A cancer-type map for withaferin A, including stronger settings such as breast and ovarian cancer and thinner exploratory areas.
- [Glioblastoma](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/wfa-evidence-by-cancer-type/glioblastoma.md): A mechanistically coherent but still thin setting for withaferin A, with relevance to HSP90, Akt/mTOR, radiosensitisation, and stem-like biology.
- [Non-Small Cell Lung Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/wfa-evidence-by-cancer-type/non-small-cell-lung-cancer.md): An emerging setting for withaferin A with evidence in EMT suppression, paclitaxel synergy, and checkpoint sensitisation.
- [Ovarian Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/wfa-evidence-by-cancer-type/ovarian-cancer.md): A leading translational setting for withaferin A because of cisplatin synergy, cancer stem cell targeting, and ongoing human trial activity.
- [Breast Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/wfa-evidence-by-cancer-type/breast-cancer.md): The strongest disease setting for withaferin A, with direct relevance to autophagy, ER-α suppression, vimentin biology, and metastasis.
- [Other Cancer Types](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/wfa-evidence-by-cancer-type/other-cancer-types.md): A summary of additional cancer settings where withaferin A has meaningful but thinner preclinical evidence.
- [Pharmacokinetics & Metabolism](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/pharmacokinetics-and-metabolism.md): Absorption, half-life, metabolism, tissue distribution, and formulation constraints for withaferin A.
- [Sourcing Quality](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/sourcing-quality.md): How to judge whether a withaferin A product is pharmacologically coherent for oncology use.
- [Safety, Interactions and WFA Dosing](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/safety-interactions-and-wfa-dosing.md): Human safety data, liver and thyroid monitoring, interaction risks, and the current dosing frame for withaferin A.
- [Hormones — ER-α and Androgens](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/hormones-er-a-and-androgens.md): What withaferin A appears to do in ER-positive breast cancer, and why older hormone-based cautions need updating.
- [Terrain Support — Liposomal WFA vs Whole-Plant Ashwagandha](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/terrain-support-liposomal-wfa-vs-whole-plant-ashwagandha.md): When whole-plant Ashwagandha fits a cancer-support protocol, and when targeted WFA is the more coherent tool.
- [Apigenin in Oncology](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/apigenin-in-oncology.md): Mechanisms, evidence quality, translational limits, and practical positioning for apigenin in oncology.
- [Evidence Summary](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/apigenin-in-oncology/evidence-summary.md): Research scope, clinical status, strengths, and limits of the apigenin oncology evidence base.
- [Anticancer Mechanisms](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/apigenin-in-oncology/anticancer-mechanisms.md): The main mechanistic routes through which apigenin shows anticancer activity in preclinical models.
- [Immune Effects](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/apigenin-in-oncology/immune-effects.md): Preclinical immune-oncology relevance of apigenin, including PD-L1 modulation, NK-cell effects, and inflammatory signalling.
- [Synergistic Combinations](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/apigenin-in-oncology/synergistic-combinations.md): Preclinical combination data for apigenin with chemotherapy, targeted agents, BH3 mimetics, and selected natural compounds.
- [Apigenin Evidence by Cancer Type](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/apigenin-in-oncology/apigenin-evidence-by-cancer-type.md): Cancer settings with the strongest dedicated apigenin signals, plus shorter notes on thinner evidence areas.
- [Colorectal Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/apigenin-in-oncology/apigenin-evidence-by-cancer-type/colorectal-cancer.md): Why colorectal cancer is one of the strongest preclinical settings for apigenin.
- [Hepatocellular Carcinoma](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/apigenin-in-oncology/apigenin-evidence-by-cancer-type/hepatocellular-carcinoma.md): Preclinical rationale for apigenin in hepatocellular carcinoma, including pathway effects and sensitisation data.
- [Prostate Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/apigenin-in-oncology/apigenin-evidence-by-cancer-type/prostate-cancer.md): One of the strongest mechanistic settings for apigenin, with Akt, NF-κB, EMT, and xenograft data.
- [Ovarian Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/apigenin-in-oncology/apigenin-evidence-by-cancer-type/ovarian-cancer.md): The clearest apigenin signal in ovarian cancer is MCL-1-linked reversal of cisplatin resistance.
- [Haematological Malignancies](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/apigenin-in-oncology/apigenin-evidence-by-cancer-type/haematological-malignancies.md): Early but mechanistically distinct apigenin data in leukaemia, myeloma, and neuroblastoma models.
- [Pharmacokinetics & Metabolism](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/apigenin-in-oncology/pharmacokinetics-and-metabolism.md): Absorption, metabolism, transporters, tissue distribution, and the main translational bottleneck for apigenin.
- [Safety & Interactions](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/apigenin-in-oncology/safety-and-interactions.md): Safety profile, CYP and transporter interactions, and practical cautions for apigenin in treatment settings.
- [Dosing & Timing](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/apigenin-in-oncology/dosing-and-timing.md): Human dose context, formulation logic, and what can and cannot be inferred from the current apigenin literature.
- [Sourcing Quality Apigenin](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/apigenin-in-oncology/sourcing-quality-apigenin.md): What makes an apigenin product credible, and where formulation quality matters most.
- [Terrain Support — SASP Suppression](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/apigenin-in-oncology/terrain-support-sasp-suppression.md): How apigenin acts as a senomorphic compound and why SASP suppression may matter in oncology.
- [Sensitisation to Conventional Therapies](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/apigenin-in-oncology/sensitisation-to-conventional-therapies.md): How apigenin may increase sensitivity to chemotherapy and related therapies in preclinical models.
- [Terrain Support](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/terrain-support.md)
- [L. reuteri in Oncology](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/terrain-support/l.-reuteri-in-oncology.md): Evidence-aware guide to Limosilactobacillus reuteri in oncology, including preclinical tumour biology, immunotherapy relevance, yoghurt preparation, capsule options, and safety cautions
- [L.reuteri hits RANKL/Bone Axis](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/terrain-support/l.-reuteri-in-oncology/l.reuteri-hits-rankl-bone-axis.md): Why L. reuteri yoghurt may be mechanistically relevant to the RANKL/OPG bone axis in ER-positive, HER2-negative breast cancer with bone involvement
- [Pu‑erh tea](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/terrain-support/pu-erh-tea.md): Evidence-aware guide to ripe Pu‑erh tea, theabrownin, metabolic terrain support, sourcing, and practical brewing


---

# Agent Instructions
This documentation is published with GitBook. GitBook is the documentation platform designed so that both humans and AI agents can read, navigate, and reason over technical content effectively. Learn more at gitbook.com.

## Querying This Documentation
If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question.

Perform an HTTP GET request on the current page URL with the `ask` query parameter, and the optional `goal` query parameter:

```
GET https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines.md?ask=<question>&goal=<endgoal>
```

`ask` is the immediate question: it should be specific, self-contained, and written in natural language.
`goal` is optional and describes the broader end goal you are ultimately trying to accomplish on behalf of the user. GitBook uses it to tailor the answer towards what is most useful for that goal.

The response will contain a direct answer to the question and relevant excerpts and sources from the documentation.

Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.